FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W895614535> ?p ?o ?g. }

• W895614535 abstract "Pancreatic cancer is one of the most aggressive malignancies, with a 5-year overall survival of less than 5%. Tumor drug resistance to conventional chemotherapy, such as gemcitabine, is often a significant contributor to poor overall survival. One of the common mechanisms of gemcitabine resistance is activation of cell signaling via increased phosphorylation of Mitogen-Activated kinase (MAP) kinases, leading to increased tumor survival and reduced sensitivity to chemotherapeutic agents. A growing body of evidence suggests that the CXCL12/CXCR4 signal transduction axis in the tumor microenvironment is an important mediator of tumor migration, growth, and drug resistance. We hypothesized that carcinoma-associated fibroblasts (CAFs), an important cellular component of the TME, play a contributory role in the growth, invasiveness, and drug response of pancreatic cancer cells (PCCs) by activating CXCL12/CXCR4-mediated signal transduction. To test this, we used an in vitro model system to study the growth, invasion, and drug response of human PCCs in the presence or absence of in vitro-generated CAFs. Functional studies demonstrated that co-culture of PCCs with CAFs led to significant increase in tumor cell invasion, which was abrogated by blockade of CXCR4 by AMD3100-plerixafor (AMD3100), a CXCR4 antagonist, and by siRNA-mediated knockdown of CXCR4 in CAFs. Increased invasion of PCCs after co-culture with orthotopically derived CAFs was also abrogated by CXCR4 blockade, demonstrating a critical role for this receptor in regulating the tumor-promoting abilities of CAFs. Additionally, we investigated the effect of CAFs on the MAPK Signaling pathway (MEK1/2, p-MEK1/2, ERK1/2, p-ERK1/2, Akt, and p-Akt) via Western blot assays. Further, we examined the effect of AMD3100 on the chemo-resistance of PCCs to gemcitabine. Our results indicated that AMD3100 reversed gemcitabine-mediated chemo-resistance of PCCs cells in the presence of CAFs or CAF-conditioned media. In co-culture with pancreatic cancer cells, CAFs induced activation of MAPK signaling pathways and enhanced transcription of Mn-SOD, G6PD, and catalase, genes involved in reactive oxygen species (ROS) pathways. Using phloretin, a ROS inhibitor, we observed attenuation of MAPK signaling, SOD activity, and reversal of drug resistance in CAF-exposed pancreatic cancer cells. These findings implicate CXCL12/CXCR4-dependent MAPK signaling and ROS pathways in CAF-mediated modulation of the growth, migration, and drug resistance of PCCs. Citation Format: Ahlim Al. Sanani, Brijsh Patel, Alix Duarte, Nitu Bansal, Tushar Bhagat, Yanique Rattigan, Anirban Maitra, Amit Verma, Debabrata Banerjee. Carcinoma-associated fibroblasts in the tumor microenvironment affect growth, invasiveness, and drug response of human pancreatic cancer cells. [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic Cancer: Innovations in Research and Treatment; May 18-21, 2014; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2015;75(13 Suppl):Abstract nr A49." @default.
• W895614535 created "2016-06-24" @default.
• W895614535 creator A5011022080 @default.
• W895614535 creator A5017551070 @default.
• W895614535 creator A5045265297 @default.
• W895614535 creator A5053723355 @default.
• W895614535 creator A5060544285 @default.
• W895614535 creator A5064181876 @default.
• W895614535 creator A5064988009 @default.
• W895614535 creator A5068938453 @default.
• W895614535 creator A5089966340 @default.
• W895614535 date "2015-06-30" @default.
• W895614535 modified "2023-09-27" @default.
• W895614535 title "Abstract A49: Carcinoma-associated fibroblasts in the tumor microenvironment affect growth, invasiveness, and drug response of human pancreatic cancer cells" @default.
• W895614535 doi "https://doi.org/10.1158/1538-7445.panca2014-a49" @default.
• W895614535 hasPublicationYear "2015" @default.
• W895614535 type Work @default.
• W895614535 sameAs 895614535 @default.
• W895614535 citedByCount "0" @default.
• W895614535 crossrefType "proceedings-article" @default.
• W895614535 hasAuthorship W895614535A5011022080 @default.
• W895614535 hasAuthorship W895614535A5017551070 @default.
• W895614535 hasAuthorship W895614535A5045265297 @default.
• W895614535 hasAuthorship W895614535A5053723355 @default.
• W895614535 hasAuthorship W895614535A5060544285 @default.
• W895614535 hasAuthorship W895614535A5064181876 @default.
• W895614535 hasAuthorship W895614535A5064988009 @default.
• W895614535 hasAuthorship W895614535A5068938453 @default.
• W895614535 hasAuthorship W895614535A5089966340 @default.
• W895614535 hasConcept C121608353 @default.
• W895614535 hasConcept C126322002 @default.
• W895614535 hasConcept C129470790 @default.
• W895614535 hasConcept C13373296 @default.
• W895614535 hasConcept C170493617 @default.
• W895614535 hasConcept C2776107976 @default.
• W895614535 hasConcept C2780210213 @default.
• W895614535 hasConcept C2780492938 @default.
• W895614535 hasConcept C3020616263 @default.
• W895614535 hasConcept C502942594 @default.
• W895614535 hasConcept C57074206 @default.
• W895614535 hasConcept C62478195 @default.
• W895614535 hasConcept C71924100 @default.
• W895614535 hasConcept C86803240 @default.
• W895614535 hasConcept C95444343 @default.
• W895614535 hasConcept C96232424 @default.
• W895614535 hasConceptScore W895614535C121608353 @default.
• W895614535 hasConceptScore W895614535C126322002 @default.
• W895614535 hasConceptScore W895614535C129470790 @default.
• W895614535 hasConceptScore W895614535C13373296 @default.
• W895614535 hasConceptScore W895614535C170493617 @default.
• W895614535 hasConceptScore W895614535C2776107976 @default.
• W895614535 hasConceptScore W895614535C2780210213 @default.
• W895614535 hasConceptScore W895614535C2780492938 @default.
• W895614535 hasConceptScore W895614535C3020616263 @default.
• W895614535 hasConceptScore W895614535C502942594 @default.
• W895614535 hasConceptScore W895614535C57074206 @default.
• W895614535 hasConceptScore W895614535C62478195 @default.
• W895614535 hasConceptScore W895614535C71924100 @default.
• W895614535 hasConceptScore W895614535C86803240 @default.
• W895614535 hasConceptScore W895614535C95444343 @default.
• W895614535 hasConceptScore W895614535C96232424 @default.
• W895614535 hasLocation W8956145351 @default.
• W895614535 hasOpenAccess W895614535 @default.
• W895614535 hasPrimaryLocation W8956145351 @default.
• W895614535 hasRelatedWork W2001394696 @default.
• W895614535 hasRelatedWork W2014103741 @default.
• W895614535 hasRelatedWork W2023218947 @default.
• W895614535 hasRelatedWork W2070905705 @default.
• W895614535 hasRelatedWork W2094609870 @default.
• W895614535 hasRelatedWork W2299200936 @default.
• W895614535 hasRelatedWork W2316941743 @default.
• W895614535 hasRelatedWork W2525472328 @default.
• W895614535 hasRelatedWork W2537969963 @default.
• W895614535 hasRelatedWork W2563829052 @default.
• W895614535 hasRelatedWork W2809791434 @default.
• W895614535 hasRelatedWork W2810553352 @default.
• W895614535 hasRelatedWork W2954205220 @default.
• W895614535 hasRelatedWork W2955259036 @default.
• W895614535 hasRelatedWork W2991555977 @default.
• W895614535 hasRelatedWork W3027075352 @default.
• W895614535 hasRelatedWork W3033064859 @default.
• W895614535 hasRelatedWork W3137563680 @default.
• W895614535 hasRelatedWork W3138656517 @default.
• W895614535 hasRelatedWork W3147752713 @default.
• W895614535 isParatext "false" @default.
• W895614535 isRetracted "false" @default.
• W895614535 magId "895614535" @default.
• W895614535 workType "article" @default.